New hope for tough pancreatic cancers: drug combo aims to shrink tumors before surgery
Disease control
Recruiting now
This early-phase trial tests a new drug called PTM-101 given alongside standard chemotherapy for people with pancreatic cancer that is either borderline resectable or locally advanced (meaning it has not spread far but is hard to remove surgically). The goal is to see if adding P…
Phase: PHASE1 • Sponsor: PanTher Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC